Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study
Metaplastic breast cancer remains poorly characterized given its rarity and heterogeneity. The majority of metaplastic breast cancers demonstrate a phenotype of triple-negative breast cancer; however, differen...
18:11
World Journal of Surgical Oncology 2020
No hay comentarios:
Publicar un comentario